One Compartment Open Model IV bolus

Slides:



Advertisements
Similar presentations
Karunya Kandimalla, Ph.D
Advertisements

PHARMACOKINETIC MODELS
PHARMACOKINETIC.
DISPOSITION OF DRUGS The disposition of chemicals entering the body (from C.D. Klaassen, Casarett and Doull’s Toxicology, 5th ed., New York: McGraw-Hill,
1-C: Renal and Hepatic Elimination
Selected bioavailability and pharmacokinetic calculations Dr. Osama A. A. Ahmed.
Pharmacokinetics of Drug Absorption
Pharmacokinetics Questions
Nonlinear pharmacokinetics
Two-compartment model
One-compartment open model: Intravenous bolus administration
Multiple IV Dosing Pharmacokinetic Research, Bioequivalence Studies,
Week 5- Pharmacokinetics of oral absorption
Week 3 - Biopharmaceutics and Pharmacokinetics
Laplace transformation
Practical Pharmacokinetics
Practical Pharmacokinetics September 11, 2007 Frank F. Vincenzi.
Week 4 - Biopharmaceutics and Pharmacokinetics
Pharmacokinetics Based on the hypothesis that the action of a drug requires presence of a certain concentration in the fluid bathing the target tissue.
Dose Adjustment in Renal and Hepatic Disease
Toxicokinetic Calculations
Gokaraju Rangaraju College of Pharmacy
INTRAVENOUS INFUSION.
CLEARANCE CONCEPTS Text: Applied Biopharm. & PK
University of Jordan-Faculty of Pharmacy
Quantitative Pharmacokinetics
The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida.
Nonlinear Pharmacokinetics Prepared By, Jahanvi H. Patel Roll No:09MPH103 Dept: Pharmaceutical Technology & Biopharmaceutics Guided By: Dhaivat C. Parikh.
Pharmacokinetics Introduction
Bioavailability Dr Mohammad Issa.
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
PHARMACOKINETIC MODELS
Touqeer Ahmed Ph.D. Atta-ur-Rahman School of Applied Bioscience, National University of Sciences and Technology 21 st October, 2013.
1-Compartment Oral Dosing 400 mg of moxifloxacin is administered orally to Mr BB, a 68 yr old male who weighs 75 kg. Blood samples were drawn following.
Area under the plasma concentration time curve. IMPORTANCE OF AUC Pharmacokinetics - measurement of bioavaibility absolute, relative Biopharmaceutics.
Drug Administration Pharmacokinetic Phase (Time course of ADME processes) Absorption Distribution Pharmaceutical Phase Disintegration of the Dosage Form.
Intravenous bolus administration: monitoring drug in urine
The General Concepts of Pharmacokinetics and Pharmacodynamics
Multiple dosing: intravenous bolus administration
Clinical Pharmacokinetics Fundamental hypothesis: a relationship exists between the pharmacological or toxic response to a drug and the accessible concentration.
Continuous intravenous infusion (one-compartment model)
BIOPHARMACEUTICS.
Nonlinear Pharmacokinetics
Clinical Pharmacokinetic Equations and Calculations
Multicompartment Models
ــــــــــــــ February 17 th, PHT - LECTURE Mathematical Fundamental in Pharmacokinetics Dr. Ahmed Alalaiwe.
The General Concepts of Pharmacokinetics and Pharmacodynamics
Time Plasma Conc (hr) (mg/L) Below limit of detection 1 Compartment IV Analysis & Renal Elimination 500 mg of tobramycin.
Objectives Compartment Modeling of Drugs Models describing drug concentration-time profiles Multi-compartment Models.
415 PHT Plasma Level – Time Curve
By : Dr. Roshini Murugupillai
Pharmacokinetics 3rd Lecture
MULTIPLE DOSAGE REGIMEN
Drug Response Relationships
Compartmental Models and Volume of Distribution
Chapter 7 COMPARTMENT MODELS
Lecture-8 Biopharmaceutics
Pharmacokinetic Modeling (describing what happens)
Chapter 1 Introduction to Biopharmaceutics & Pharmacokinetics
Quantitative Pharmacokinetics
School of Pharmacy, University of Nizwa
Clinical Pharmacokinetics
Hawler Medical University
Selected Bioavailability and Pharmacokinetic Calculations
1 Concentration-time curve
Biopharmaceutics Chapter-6
Hawler Medical University
School of Pharmacy, University of Nizwa
Presentation transcript:

One Compartment Open Model IV bolus Dr Mohammad Issa

One compartment

More than one compartment

One compartment open model The one-compartment open model offers the simplest way to describe the process of drug distribution and elimination in the body. This model assumes that the drug can enter or leave the body (ie, the model is "open"), and the body acts like a single, uniform compartment. The simplest route of drug administration from a modeling perspective is a rapid intravenous injection (IV bolus).

One compartment open model The simplest kinetic model that describes drug disposition in the body is to consider that the drug is injected all at once into a box, or compartment, and that the drug distributes instantaneously and homogenously throughout the compartment. Drug elimination also occurs from the compartment immediately after injection.

One compartment:

Properties of a Pharmacokinetic Compartment Kinetic homogeneity. A compartment contains tissues that can be grouped according to similar kinetic properties to the drug allowing for rapid distribution between tissues Although tissues within a compartment are kinetically homogeneous, drug concentrations within a compartment may have different concentrations of drug depending on the partitioning and binding properties of the drug. Within each compartment, distribution is immediate and rapidly reversible. Compartments are interconnected by first-order rate constants. Input rate constants may be zero order

One compartment: IV bolus administration (dose = X0) Drug amount in the Body (X) IV bolus administration (dose = X0) Elimination process Elimination rate constant (K) Based on the assumption of first order elimination process:

One compartment open model C= concentration D= dose Vd: Volume of distribution K: elimination rate constant t: time Drug Conc (C) Time

How to distinguish one comp? Plotting log(C) vs. time yields a straight line log (C) Time

Fundamental parameters in one compartment Apparent Volume of Distribution (Vd) Elimination rate constant (K) Elimination half life (t1/2) Clearance (Cl)

Apparent Volume of Distribution (Vd) 100 mg C= 10 mg/L C= 1 mg/L Vd= 10 L Vd= 100 L

Apparent Volume of Distribution (Vd) In general, drug equilibrates rapidly in the body. When plasma or any other biologic compartment is sampled and analyzed for drug content, the results are usually reported in units of concentration instead of amount Each individual tissue in the body may contain a different concentration of drug due to differences in drug affinity for that tissue. Therefore, the amount of drug in a given location can be related to its concentration by a proportionality constant that reflects the volume of fluid the drug is dissolved in The volume of distribution represents a volume that must be considered in estimating the amount of drug in the body from the concentration of drug found in the sampling compartment

The real Volume of Distribution has physiological meaning and is related to body water Total body water 42 L Plasma Plasma volume 4 L Interstitial fluid Interstitial fluid volume 10 L Intracellular fluid Intracellular fluid volume 28 L

Apparent Volume of Distribution Drugs which binds selectively to plasma proteins, e.g. Warfarin have apparent volume of distribution smaller than their real volume of distribution Drugs which binds selectively to extravascular tissues, e.g. Chloroquines have apparent volume of distribution larger than their real volume of distribution. The Vd of such drugs is always greater than 42 L (Total body water)

Apparent Volume of Distribution Lipid solubility of drug Degree of plasma protein binding Affinity for different tissue proteins Fat : lean body mass Disease like Congestive Heart Failure (CHF), uremia, cirrhosis

Apparent Volume of Distribution In general, drug equilibrates rapidly in the body. When plasma or any other biologic compartment is sampled and analyzed for drug content, the results are usually reported in units of concentration instead of amount Each individual tissue in the body may contain a different concentration of drug due to differences in drug affinity for that tissue. Therefore, the amount of drug in a given location can be related to its concentration by a proportionality constant that reflects the volume of fluid the drug is dissolved in The volume of distribution represents a volume that must be considered in estimating the amount of drug in the body from the concentration of drug found in the sampling compartment

Apparent Volume of Distribution: Mathematics In order to determine the apparent volume of distribution of a drug, it is necessary to have plasma/serum concentration versus time data

Apparent volume of distribution estimation Plot log(C) vs. time Plot the best-fit line Extrapolate to the Y-axis intercept (to estimate initial concentration, C0) Estimate Vd:

1- Plot log(C) vs. time Log (Conc) Time

2- Plot the best-fit line Log (Conc) Time

3-Extrapolate to the Y-axis intercept (to estimate C0) Log (Conc) C0 Time

4-Estimate Vd Log (Conc) Log(C0) Time

The Extent of Distribution and Vd in a 70 kg Normal Man Vd, L % Body Weight Extent of Distribution 5 7 Only in plasma 5-20 7-28 In extracellular fluids 20-40 28-56 In total body fluids. >40 >56 In deep tissues; bound to peripheral tissues

Elimination rate constant (K) Elimination rate constant represents the fraction of drug removed per unit of time K has a unit of reciprocal of time (e.g. minute-1, hour-1, and day-1) With first-order elimination, the rate of elimination is directly proportional to the serum drug concentration

Elimination rate constant estimation Plot log(C) vs. time Plot the best-fit line Calculate the slope using two points on the best-fit line Estimate K:

1- Plot log(C) vs. time Log (Conc) Time

2- Plot the best-fit line Log (Conc) Time

3- Calculate the slope using two points on the best-fit lin Log (Conc) (Log(C1), t1) (Log(C2), t2) Time

4- Estimate K Log (Conc) Time

Elimination half life (t1/2) The elimination half life is sometimes called ‘‘biological half-life’’ of a drug The elimination half life is defined as the time (h, min, day, etc.) at which the mass (or amount) of unchanged drug becomes half (or 50%) of the initial mass of drug

Elimination half life (t1/2) estimation Two methods: From the value of K: Directly from Conc vs. time plot Select a concentration on the best fit line (C1) Look for the time that is needed to get to 50% of C1  half-life

Clearance (Cl) Clearance is a measure of the removal of drug from the body Plasma drug concentrations are affected by the rate at which drug is administered, the volume in which it distributes, and its clearance A drug’s clearance and the volume of distribution determine its half life

Clearance (Cl) Clearance (expressed as volume/time) describes the removal of drug from a volume of plasma in a given unit of time (drug loss from the body) Clearance does not indicate the amount of drug being removed. It indicates the volume of plasma (or blood) from which the drug is completely removed, or cleared, in a given time period. Figures in the following two slides represent two ways of thinking about drug clearance: In the first Figure, the amount of drug (the number of dots) decreases but fills the same volume, resulting in a lower concentration Another way of viewing the same decrease would be to calculate the volume that would be drug-free if the concentration were held constant as resented in the second Figure

Clearance (Cl) the amount of drug (the number of dots) decreases but fills the same volume, resulting in a lower concentration

Clearance (Cl)

Clearance (Cl) The most general definition of clearance is that it is ‘‘a proportionality constant describing the relationship between a substance’s rate of elimination (amount per unit time) at a given time and its corresponding concentration in an appropriate fluid at that time.’’ Clearance can also be defined as ‘‘the hypothetical volume of blood (plasma or serum) or other biological fluids from which the drug is totally and irreversibly removed per unit time.’’

Clearance (Cl) estimation For ALL LINEAR pharmacokinetics (including one compartment) , clearance is calculated using: where AUC is the area under the concentration curve (it will be discussed later)

Clearance (Cl) estimation For One compartment pharmacokinetics , clearance is calculated using:

Clearance (Cl) Drugs can be cleared from the body by different pathways, or organs, including hepatic biotransformation and renal and biliary excretion. Total body clearance of a drug is the sum of all the clearances by various mechanisms.

Elimination rate The elimination rate at any time can be calculated using: Elimination rate = K*X(t) OR Elimination rate = Cl*C(t) where X(t) is the amount of drug in the body at time t, C(t) is the concntration of drug at time t

Area Under the Conc. Time Curve (AUC) calculation Two methods: Model dependent: can be used only for one compartment IV bolus Model independent: Can be used for any drug with any route of administration

AUC calculation: Model dependent With one compartment model, first-order elimination, and intravenous drug administration, the AUC can be calculated using:

AUC calculation: Model independent

AUC calculation: Model independent 1- Divide the area into different parts based on the observed concentration points (parts 1-5) 1 2 3 4 5

AUC calculation: Model independent 2- Calculate the area for each part of the parts 1,2,3 and 4 (until the last observed concentration) using trapezoidal rule 1 2 3 4 5

Trapezoidal rule (Trapezoid = شبه المنحرف) C1 C2 where C = concentration t = time t1 t2

AUC calculation: Model independent 3- For part 5 (area between the last observed concentration and infinity) use the following equation: C*

AUC calculation: Model independent 4- The total AUC (from zero to infinity) is the sum of the areas of parts: 1,2,3,4, and 5 1 2 3 4 5

Fraction of the dose remaining Fraction of dose remainig (F = X(t)/X0) is given by the following equation: since t1/2= 0.693/k, the equation can be represented as:

Time to get to certain conc. Time to get to certain concentration (C*) is given by:

Applications of one compartment model Case 1: Predicting Plasma Concentrations Case 2: Duration of Action Case 3:Value of a Dose to Give a Desired Initial Plasma Concentration

Case 1: Predicting Plasma Concentrations A 20-mg dose of a drug was administered as an intravenous bolus injection. The drug has the following pharmacokinetic parameters: k = 0.1 h−1 and Vd = 20 L Calculate the initial concentration (C0 ) Calculate the plasma concentration at 3 h

Case 1: Predicting Plasma Concentrations Calculate the initial concentration (C0 ) Calculate the plasma conc. at 3 h

Case 2: Duration of Action The duration of action of a drug may be considered to be the length of time the plasma concentration spends above the MEC. Its determination is best illustrated by example 2.

Case 2: Duration of Action Continuing with the drug used in Example 1, if the therapeutic range is between 5 and 0.3 mg/L, how long are the plasma concentrations in the therapeutic range?

Case 2: Duration of Action As indicated in the diagram (previous slide) C0 =1 mg/L. Thus, at time zero the plasma concentration is in the therapeutic range. The plasma concentration will remain therapeutic until it falls to the MEC (0.3 mg/L). At what time does this occur?

Case 3: Value of a Dose to Give a Desired Initial Plasma Concentration Continuing with the drug used in Examples 1 and 2, If the initial Cp of 1 mg/L is unsatisfactory, Calculate a dose to provide an initial plasma concentration of 5 mg/L.

Examples

Example 1 Ten mg metoclopramide was administered intravenously to a 72 kg patient. The minimum plasma concentration required to cause significant enhancement of gastric emptying is 50 ng/mL. The following plasma concentrations were observed after analysis of the specimen.

Example 1 Time (hr) Conc. (ng/ml) 1 90.0 2 68.0 4 40.0 6 21.5 8 12.0 10 7.0

Example 1 Calculate the biological half-life of the drug elimination (t½), the overall elimination rate constant (K), the volume (Vd), the coefficient of distribution and the duration of action (td)

Example 1

Example 1 The elimination rate constant can be obtained from the slope: Another way to calculate the slope is using:

Example 1 Another way to calculate the slope (if you do not have the ability to do regression) is using: where (C1,t1) and (C2,t2) are two different conc. time points It is important to note that the first method for calculating the slope is more accurate

Example 1 Calculating the slope using the second method: Note that the value of the slope is similar to the value estimated using the first method (-0.1243)

Example 1 the biological half-life of the drug elimination (t½): The volume of distribution (Vd):

Example 1 Intercept = log (C0) C0= 10intecept

Example 1 the coefficient of distribution = Vd/wt =83 L/ 72 kg= 1.15 L/kg the duration of action (td). td is the time needed for the conc. To get to 50 ng/ml :

Example 2 An adult male patient was given the first dose of an antibiotic at 6:00 AM. At 12:00 noon the plasma level of the drug was measured and reported as 5 µg/ml. The drug is known to follow the one compartment model with a half-life of 6 hours. The recommended dosage regimen of this drug is 250 mg q.i.d. the minimum inhibitory concentration is 3 µg/ml. Calculate the following: Apparent volume of distribution Expected plasma concentration at 10 AM. Duration of action of the first dose Total body clearance Fraction of the dose in the body 5 hours after the injection Total amount in the body 5 hours after the injection Cumulative amount eliminated 5 hours after the injection Total amount in the body immediately after injection of a second dose at 12:00 noon Duration of action of first dose only if dose administered at 6:00 AM was 500 mg.

Example 2 Elimination rate constant: Initial concentration: The conc. at 12:00 noon (6 hrs after the first dose) is 5 µg/ml:

Example 2 Apparent volume of distribution: C(t=6hrs)= 5 ug/ml. Since the half life is 6 hrs, C0 = 10 ug/ml. Expected plasma concentration at 10 AM

Example 2 Duration of action of the first dose Total body clearance Fraction of the dose in the body 5 hours after the injection

Example 2 Total amount in the body 5 hours after the injection = (0.56)(250 mg) = 140 mg Cumulative amount eliminated 5 hours after the injection = dose – amount in the body = 250 – 140 = 110 mg Total amount in the body immediately after injection of a second dose at 12:00 noon Total amount = amount from the first dose + amount from the second dose = 125 + 250 = 375 mg

Example 2 Duration of action of first dose only if dose administered at 6:00 AM was 500 mg Note that 6 hrs (one t0.5) is needed for the amount in the body to decline from 500 mg to 250 mg

Example 3 The therapeutic range of a drug is 20-200 mg/L. After an intravenous bolus injection of 1.0 gm followed by regression analysis of the concentration of the drug in plasma (in units of mg/L) versus time (in hours), the following linear equation was obtained Calculate the following Duration of action Total body clearance Rate of elimination at 2 hours

Example 3 From the equation: The following were estimated:

Example 3 Duration of action: Total body clearance= K∙Vd=(0.23)(10) =2.3 L/hr Rate of elimination at 2 hours: Elimination rate = Cl*C(t=2) = 2.3*63 =145 mg/hr